Novalis Lifesciences Investments
Novalis LifeSciences Investments II, L.P.
Late investment periodEmerging manager
Late investment period: first sale Oct 2021, per Form D (fund age approximates vintage)
- Vintage
- 2021
- Fund size
- $296.8M (Form D)
- Stages
- Not stated
- Sectors
- Life sciences and research tools, Biotech
- Regions
- Not stated
01 · Thesis
Novalis Capital Partners makes direct venture capital and private equity investments in life science companies, focusing on life science tools, diagnostics, and biopharma therapeutics. It backs visionary life science entrepreneurs.Inferred from the firm's website
02 · Initial check
$2.97M to $4.95M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- PAUL MEISTER
- MARIJN DEKKERS
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideNovalis Capital Partners is a boutique investment and advisory firm for the Life Science industry that invests in life science tools, diagnostics, and biopharma therapeutics companies.
Novalis Capital Partners is a boutique investment and advisory firm for the Life Science industry that was founded in 2017 by Marijn E. Dekkers.
https://www.novalislifesciences.com/
06 · Sources
Last verified: Oct 28, 2026